신규한 인돌 유도체 및 이를 포함하는 항암 조성물
Cited 0 time in 
Metadata Downloads
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김보연 | - |
| dc.contributor.author | 성낙균 | - |
| dc.contributor.author | 라오 | - |
| dc.contributor.author | 안종석 | - |
| dc.contributor.author | 이경호 | - |
| dc.contributor.author | 차현주 | - |
| dc.contributor.author | 황준성 | - |
| dc.contributor.author | 장재혁 | - |
| dc.contributor.author | 고성균 | - |
| dc.contributor.author | 류인자 | - |
| dc.date.accessioned | 2021-10-05T15:31:10Z | - |
| dc.date.available | 2021-10-05T15:31:10Z | - |
| dc.date.issued | 2021-09-30 | - |
| dc.identifier.other | 14213AU-1 | - |
| dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/24828 | - |
| dc.title | 신규한 인돌 유도체 및 이를 포함하는 항암 조성물 | - |
| dc.title.alternative | Novel indole derivatives and composition comprising thereof for anti-cancer | - |
| dc.type | Patent | - |
| dc.date.registration | 2021-09-30 | - |
| dc.contributor.affiliatedAuthor | 김보연 | - |
| dc.contributor.affiliatedAuthor | 성낙균 | - |
| dc.contributor.affiliatedAuthor | 라오 | - |
| dc.contributor.affiliatedAuthor | 안종석 | - |
| dc.contributor.affiliatedAuthor | 이경호 | - |
| dc.contributor.affiliatedAuthor | 차현주 | - |
| dc.contributor.affiliatedAuthor | 황준성 | - |
| dc.contributor.affiliatedAuthor | 장재혁 | - |
| dc.contributor.affiliatedAuthor | 고성균 | - |
| dc.contributor.affiliatedAuthor | 류인자 | - |
| dc.date.application | 2018-08-15 | - |
| dc.identifier.patentApplicationNumber | 2017221673 | - |
| dc.identifier.patentRegistrationNumber | 2017221673 | - |
| dc.publisher.location | 호주 | - |
| dc.contributor.assignee | 한국생명공학연구원 | - |
| dc.contributor.inventor | 김보연 | - |
| dc.description.patentCountryDivision | 국외 | - |
- Appears in Collections:
- Ochang Branch Institute > Chemical Biology Research Center > 2. Patents
Ochang Branch Institute > Nucleic Acid Therapeutics Research Center > 2. Patents
- Files in This Item:
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.